Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
ENANTIOS logo — Instrumentation and services for the characterization of chi...

ENANTIOS

Instrumentation and services for the characterization of chiral molecules

Founded 2022 2 employees Seed Total: $1.80M Biotechnology, Pharmaceutical

General Information

Company Name ENANTIOS
Founded Year 2022
Employees 2
Industries Biotechnology, Pharmaceutical
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with ENANTIOS. To contact ENANTIOS, visit enantios.com .

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About ENANTIOS

Enantios is a biotechnology and pharmaceutical startup company founded in 2022. Specializing in the field of biotechnology and pharmaceuticals, Enantios is primed to make a significant impact on the industry with their innovative approaches. As of now, there is no specific information available about their headquarters, slogan, or any recent investment activity. However, given the potential of the biotechnology and pharmaceutical sectors, Enantios presents an intriguing opportunity for investors seeking to capitalize on emerging trends in the healthcare and life sciences landscape. With a clear focus on cutting-edge research and development, Enantios is positioned to attract interest from forward-thinking investors looking to support groundbreaking advancements in these critical fields.

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Fr.1.80M 2
Privilège Ventures LBank
Privilège Ventures, LBank
01 Jun 2024
Support Program Undisclosed 1
SWISS INVESTMENT CORPORATION
SWISS INVESTMENT CORPORATION
01 Jan 2024
Spinout Undisclosed 1
ESA BIC Switzerland
ESA BIC Switzerland
01 Jan 2023

FAQ About ENANTIOS

Instrumentation and services for the characterization of chiral molecules
ENANTIOS was founded in 2022.
ENANTIOS operates in Biotechnology and Pharmaceutical.
ENANTIOS has approximately 2 employees.
ENANTIOS has completed 3 funding rounds, raising a total of $1.80M. The latest funding stage is Seed.

We're actively collecting intelligence on ENANTIOS.

Source: BounceWatch company record for ENANTIOS, https://bouncewatch.com/company/enantios, updated 4 November 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes